NASDAQ: VKTX - Viking Therapeutics, Inc.

Yield per half year: +3.03%
Sector: Healthcare

Reporting Viking Therapeutics, Inc.

Capitalization

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Капитализация, млрд $
0.0371 0.023 0.0436 0.5236 0.5688 0.4697 0.4758 0.2659 1.38 1.51
Выручка, млрд $
0.0000 0.0000
Чистая прибыль, млрд $
-0.0234 -0.0147 -0.0206 -0.0221 -0.0258 -0.0395 -0.0543 -0.0674 -0.0859 -0.0859
EV, млрд $
0.0406 0.4503 0.5514 0.38 0.3288 0.6142 1.74 1.74
EBIT, млрд $
-0.012 -0.0138 -0.0191 -0.0221 -0.0327 -0.0395 -0.0557 -0.0706 -0.1008 -0.1008
EBITDA, млрд $
-0.0224 -0.0129 -0.0193 -0.0217 -0.0255 0.0038 -0.0557 -0.0703 -0.1008 -0.1008
Баланс стоимость, млрд $
0.0087 0.008 0.0135 -0.1029 -0.1287 -0.1682 -0.2232 0.1453 0.3484 0.3484
FCF, млрд $
-0.0087 -0.0111 -0.0148 -0.0188 -0.0248 -0.0218 -0.0476 -0.0484 -0.0734 -0.0734
Операционный денежный поток, млрд $
-0.0087 -0.0111 -0.0148 -0.0188 -0.0248 -0.0218 -0.0476 -0.0484 -0.0734 -0.0734
Операционная прибыль, млрд $
-0.012 -0.0138 -0.0191 -0.0262 -0.0327 -0.0427 -0.0557 -0.0704 -0.1008 -0.1008
Операционные расходы, млрд $
0.012 0.0138 0.0191 0.0262 0.0327 0.0427 0.0557 0.0704 0.1008 0.1008


Balance sheet

IFRS
Reporting Annual Quarterly
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Наличность, млрд $
0.000769 0.0031 0.009 0.0248 0.0084 0.0291 0.0264 0.0366 0.0555 0.0555
Short Term Investments $
0.0133 0.0101 0.0116 0.2767 0.2673 0.2193 0.1757 0.1189 0.3066 0.3066
Total Current Assets $
0.0152 0.014 0.0219 0.3021 0.2835 0.2561 0.2105 0.167 0.3672 0.3672
Чистые активы, млрд $
0.2978 0.2771 0.2443 0.2019 0.0014 0.1341 0.167
Активы, млрд $
0.0154 0.0145 0.0221 0.3023 0.2843 0.2565 0.2107 0.1685 0.3685 0.3685
Short Term Debt $
0.000304 0.0022 0.0033 0.0035 0.000302 0.00033 0.0000 0.000304 0.000324 0.000324
Long Term Debt $
0.000232 0.0013 0.0022
Задолженность, млрд $
0.0067 0.0065 0.0087 0.0046 0.0071 0.0122 0.0088 0.0232 0.0201 0.0201
Чистый долг, млрд $
0.0014 0.000194 -0.0055 -0.0248 -0.0077 -0.0288 -0.0263 -0.0351 -0.0543 -0.0543
Долг, млрд $
0.000279 0.0016 0.0043 0.000662 0.000359 0.0000 0.0016 0.0013 0.0013
Interest income $
0.000982 0.0019 0 0.0032 0.0071 0.0032 0.000703 0.0016 0.011
Расходы на обслуживание долга $
0.000982 0.0018 0.0013 0.000404 0.000146 0.000106 0.000692 0.0015 0.0001 0.0001
Чист. проц. доходы, млрд $
-0.0019 -0.0019 0.0032 0.0071 0.0032 0.000703 0.0016 0.011 0.011
Амортизация, млрд $
-0.0104 0.000925 -0.000225 0.0045 0.0072 0.0038 0 0.000291 0.000292 0.000292
Себестоимость, млрд $
0.00026 0.000277 0.000296 0.000291 0.000292 0.000292


Share

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
EPS -3.56 -1 -0.8 -0.3832 -0.3582 -0.544 -0.7034 -0.8769 -0.9104 -0.9104
Цена акции ао 1.44 1.68 9.03 7.9 6.43 6.18 9.4 18.61 65.84 65.84
Число акций ао, млн 6 16 26 57.58 71.96 72.6 77.2 76.83 94.35 94.35
FCF/акцию -1.46 -0.692 -0.5676 -0.3257 -0.344 -0.3 -0.6164 -0.6299 -0.7777 -0.7777


Efficiency

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Industry average 5 year average CAGR 5
ROE, % -268.24 -183.17 -152.83 -14.18 -8.97 -15.15 -24.34 -46.37 -24.65 -24.65 29.22
ROA, % -151.59 -101.35 -93.02 -13.6 -8.79 -14.61 -23.25 -39.98 -23.31 -23.31 9.39
ROS, % -368045.85 -504644.43 0 0 0 23.20
ROCE, % -137.5 -172.17 -141.63 -7.41 -11.78 -16.16 -27.58 -48.58 -28.94 -28.94 35.06
Рентаб EBITDA, % 35117.93 -520409.31 0 31.15
Чистая рентаб, % -368045.85 -507410.52 0 23.20
Operation Margin, % -397558.48 -520343.89 0 0 0 27.00
Доходность FCF, % -23.56 -48.08 -33.81 -3.58 -4.35 -4.64 -10 -18.2 -5.33


Coefficients

IFRS
Reporting Annual Quarterly
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Industry average 5 year average CAGR 5
P/E
-1.58 -1.56 -2.12 -23.73 -22.06 -11.89 -8.81 -3.95 -16.04 30.88
P/BV
4.25 2.86 3.24 1.6 2.02 1.67 1.76 4.47 5.14 5.14 7.77
P/S
38087.89 34122.66 7.31
P/FCF
-2.08 -2.96 -27.92 -22.98 -21.57 -10 -5.49 -31.2 -20.58 -20.58 38.30
E/P
-0.6397 -0.4715 -0.0421 -0.0453 -0.0841 -0.1135 -0.2534 -0.0623 -0.0569 -0.0569 0.04
EV/EBITDA
-1.81 -18.98 -21.6 100.83 -6.08 -8.73 -17.24 -17.24 24.22
EV/Ebit
-17.24 -17.24
EV/S
35407.8 30723.05 0 0 0 7.59
EV/FCF
-4.65 -22.28 -17.45 -6.91 -12.69 -23.69 -23.69 -23.69 44.10
Debt/EBITDA
-2.29 -0.0738 -0.1919 -0.0259 0.0953 -0.000521 -0.0222 -0.0125 -0.0125 -0.0125 2.24
Netdebt/Ebitda
-0.015 0.287 1.14 0.3023 -7.63 0.473 0.4987 0.5381 0.5381 0.5381 1.14
Debt/Ratio
1.55 0.5153 0.2787 0.0023 0.0014 0.000138 0.0093 0.0034 0.0034 0.0034 0.23
Debt/Equity
-1.11 -0.0709 0.4932 0.0024 0.0015 0.000144 0.0108 0.0036 0.0075 0.0075 2.62
Debt/Net Income
-1.91 -0.0717 -0.1839 -0.0257 -0.0091 -0.000537 -0.0232 -0.0147 -0.0147 -0.0147 3.25
Бета
3.66 3.8 3.8 0.06
Индекс Альтмана
2.02 1.48 6.92 2.52 2.52 -65.41


Dividends

IFRS
Reporting Annual
2016 LTM Industry average 5 year average CAGR 5
Див.выплата, млрд
2.2E-5
Дивиденд
0
Див доход, ао, %
0 1.86
Дивиденды / прибыль, %
-0.1513 0 41.83


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
22 27